(Total Views: 544)
Posted On: 05/02/2020 11:50:29 AM
Post# of 154094
In communion with a beautiful sun-shinning Saturday let me fantasize a bit:
Let's asume we are approved for first line of defense in Mild to Moderate COVID . Let's asume that we can produce larger quantities of Leronlimab (will need government or heavy-weights support for sure). The potential market is in the Billions (with B). Let's asume that we will sell only a Billion doses (again, with governments support), and we make a profit only $100 per dose (this is a laughable amount but, heck, is sunny out there today and I am in a good mood).
We will receive 1B X $100 = $100B. Let me assume that this is not a recurrent problem (it will be) we will get a total of $142 price per fully diluted share.
Let's asume we are approved for first line of defense in Mild to Moderate COVID . Let's asume that we can produce larger quantities of Leronlimab (will need government or heavy-weights support for sure). The potential market is in the Billions (with B). Let's asume that we will sell only a Billion doses (again, with governments support), and we make a profit only $100 per dose (this is a laughable amount but, heck, is sunny out there today and I am in a good mood).
We will receive 1B X $100 = $100B. Let me assume that this is not a recurrent problem (it will be) we will get a total of $142 price per fully diluted share.
(7)
(0)
